Abakavir/lamivudin Remedica 600 mg/300 mg filmom obložene tablete
| Name | Abakavir/lamivudin Remedica 600 mg/300 mg filmom obložene tablete |
|---|---|
| Former Name | Abakavir/Lamivudin Alpha-Medical 600 mg/300 mg filmom obložene tablete |
| Marketing Authorisation Number | HR-H-623446421 |
| Active Substance | abakavir lamivudin |
| Composition | jedna filmom obložena tableta sadrži 600 mg abakavira i 300 mg lamivudina |
| Pharmaceutical Form | filmom obložena tableta |
| Manufacturer | Remedica Ltd., Limassol, Cipar |
| Marketing Authorisation Holder | Remedica Ltd., Aharnon Street, Limassol Industrial Estate, Limassol, Cipar |
| Marketing Authorisation Date | 07.01.2022 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/21-02/64 |
| Registration Number | 381-12-01/154-22-05 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ograničeni recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | J05AR02 |
| Marketing status | privremeni prekid opskrbe |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
| Educational materials for healthcare professionals |
Prezentacija za zdravstvene radnike, verzija 3 |
